581 related articles for article (PubMed ID: 2547410)
41. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations.
Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA
Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443
[TBL] [Abstract][Full Text] [Related]
42. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
Hausmann L; Goebel KM; Zehner J
Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
[TBL] [Abstract][Full Text] [Related]
43. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
44. Contraceptive steroid effects on nonreproductive organ systems.
Corson SL
J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
[TBL] [Abstract][Full Text] [Related]
45. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
Skouby SO; Andersen O; Kühl C
Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
[TBL] [Abstract][Full Text] [Related]
46. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB
Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983
[TBL] [Abstract][Full Text] [Related]
47. Clinical and metabolic considerations of long-term oral contraceptive use.
Godsland IF; Crook D; Wynn V
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1955-63. PubMed ID: 1605285
[TBL] [Abstract][Full Text] [Related]
48. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
Nelson AL
Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
[TBL] [Abstract][Full Text] [Related]
49. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
[TBL] [Abstract][Full Text] [Related]
50. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
51. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins.
Patsch W; Brown SA; Gotto AM; Young RL
Am J Obstet Gynecol; 1989 Nov; 161(5):1396-401. PubMed ID: 2686455
[TBL] [Abstract][Full Text] [Related]
52. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
53. Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle.
Schijf CP; van der Mooren MJ; Doesburg WH; Thomas CM; Rolland R
Acta Endocrinol (Copenh); 1993 Aug; 129(2):130-3. PubMed ID: 8372597
[TBL] [Abstract][Full Text] [Related]
54. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
Moller SE; Moller BM; Olesen M; Fjalland B
Eur J Clin Pharmacol; 1996; 50(3):179-84. PubMed ID: 8737756
[TBL] [Abstract][Full Text] [Related]
55. Effects of estrogens and progestogens on lipid metabolism.
Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
[TBL] [Abstract][Full Text] [Related]
56. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
57. Hormonal contraception.
Baird DT; Glasier AF
N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
[TBL] [Abstract][Full Text] [Related]
58. Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen.
Fotherby K
Contraception; 1992 Nov; 46(5):477-88. PubMed ID: 1458894
[TBL] [Abstract][Full Text] [Related]
59. Androgenic, anabolic, estrogenic and antiestrogenic effects of desogestrel and lynestrenol: effects on serum proteins and vaginal cytology.
Cullberg G
Contraception; 1984 Jul; 30(1):73-9. PubMed ID: 6236952
[TBL] [Abstract][Full Text] [Related]
60. Coronary heart disease risk markers in users of low-dose oral contraceptives.
Godsland IF; Crook D; Wynn V
J Reprod Med; 1991 Mar; 36(3 Suppl):226-37. PubMed ID: 2046076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
